Report Detail

Medical Industry Global Preclinical Drug Development Services Market Research Report 2022

  • RnM4438727
  • |
  • 11 May, 2022
  • |
  • Global
  • |
  • 89 Pages
  • |
  • QYResearch
  • |
  • Medical Industry

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global Preclinical Drug Development Services Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
      • 1.2.2 API Preparation
      • 1.2.3 Formulation Studies
      • 1.2.4 Safety Studies
      • 1.2.5 ADME Stuies
    • 1.3 Market by Application
      • 1.3.1 Global Preclinical Drug Development Services Market Share by Application: 2017 VS 2021 VS 2028
      • 1.3.2 Pharmaceutical
      • 1.3.3 Bio-pharmaceutical
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Global Growth Trends

    • 2.1 Global Preclinical Drug Development Services Market Perspective (2017-2028)
    • 2.2 Preclinical Drug Development Services Growth Trends by Region
      • 2.2.1 Preclinical Drug Development Services Market Size by Region: 2017 VS 2021 VS 2028
      • 2.2.2 Preclinical Drug Development Services Historic Market Size by Region (2017-2022)
      • 2.2.3 Preclinical Drug Development Services Forecasted Market Size by Region (2023-2028)
    • 2.3 Preclinical Drug Development Services Market Dynamics
      • 2.3.1 Preclinical Drug Development Services Industry Trends
      • 2.3.2 Preclinical Drug Development Services Market Drivers
      • 2.3.3 Preclinical Drug Development Services Market Challenges
      • 2.3.4 Preclinical Drug Development Services Market Restraints

    3 Competition Landscape by Key Players

    • 3.1 Global Top Preclinical Drug Development Services Players by Revenue
      • 3.1.1 Global Top Preclinical Drug Development Services Players by Revenue (2017-2022)
      • 3.1.2 Global Preclinical Drug Development Services Revenue Market Share by Players (2017-2022)
    • 3.2 Global Preclinical Drug Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.3 Players Covered: Ranking by Preclinical Drug Development Services Revenue
    • 3.4 Global Preclinical Drug Development Services Market Concentration Ratio
      • 3.4.1 Global Preclinical Drug Development Services Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by Preclinical Drug Development Services Revenue in 2021
    • 3.5 Preclinical Drug Development Services Key Players Head office and Area Served
    • 3.6 Key Players Preclinical Drug Development Services Product Solution and Service
    • 3.7 Date of Enter into Preclinical Drug Development Services Market
    • 3.8 Mergers & Acquisitions, Expansion Plans

    4 Preclinical Drug Development Services Breakdown Data by Type

    • 4.1 Global Preclinical Drug Development Services Historic Market Size by Type (2017-2022)
    • 4.2 Global Preclinical Drug Development Services Forecasted Market Size by Type (2023-2028)

    5 Preclinical Drug Development Services Breakdown Data by Application

    • 5.1 Global Preclinical Drug Development Services Historic Market Size by Application (2017-2022)
    • 5.2 Global Preclinical Drug Development Services Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Preclinical Drug Development Services Market Size (2017-2028)
    • 6.2 North America Preclinical Drug Development Services Market Size by Country (2017-2022)
    • 6.3 North America Preclinical Drug Development Services Market Size by Country (2023-2028)
    • 6.4 United States
    • 6.5 Canada

    7 Europe

    • 7.1 Europe Preclinical Drug Development Services Market Size (2017-2028)
    • 7.2 Europe Preclinical Drug Development Services Market Size by Country (2017-2022)
    • 7.3 Europe Preclinical Drug Development Services Market Size by Country (2023-2028)
    • 7.4 Germany
    • 7.5 France
    • 7.6 U.K.
    • 7.7 Italy
    • 7.8 Russia
    • 7.9 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific Preclinical Drug Development Services Market Size (2017-2028)
    • 8.2 Asia-Pacific Preclinical Drug Development Services Market Size by Country (2017-2022)
    • 8.3 Asia-Pacific Preclinical Drug Development Services Market Size by Country (2023-2028)
    • 8.4 China
    • 8.5 Japan
    • 8.6 South Korea
    • 8.7 Southeast Asia
    • 8.8 India
    • 8.9 Australia

    9 Latin America

    • 9.1 Latin America Preclinical Drug Development Services Market Size (2017-2028)
    • 9.2 Latin America Preclinical Drug Development Services Market Size by Country (2017-2022)
    • 9.3 Latin America Preclinical Drug Development Services Market Size by Country (2023-2028)
    • 9.4 Mexico
    • 9.5 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa Preclinical Drug Development Services Market Size (2017-2028)
    • 10.2 Middle East & Africa Preclinical Drug Development Services Market Size by Country (2017-2022)
    • 10.3 Middle East & Africa Preclinical Drug Development Services Market Size by Country (2023-2028)
    • 10.4 Turkey
    • 10.5 Saudi Arabia
    • 10.6 UAE

    11 Key Players Profiles

    • 11.1 Wuxi AppTec
      • 11.1.1 Wuxi AppTec Company Detail
      • 11.1.2 Wuxi AppTec Business Overview
      • 11.1.3 Wuxi AppTec Preclinical Drug Development Services Introduction
      • 11.1.4 Wuxi AppTec Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.1.5 Wuxi AppTec Recent Development
    • 11.2 Labcorp
      • 11.2.1 Labcorp Company Detail
      • 11.2.2 Labcorp Business Overview
      • 11.2.3 Labcorp Preclinical Drug Development Services Introduction
      • 11.2.4 Labcorp Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.2.5 Labcorp Recent Development
    • 11.3 Charles River
      • 11.3.1 Charles River Company Detail
      • 11.3.2 Charles River Business Overview
      • 11.3.3 Charles River Preclinical Drug Development Services Introduction
      • 11.3.4 Charles River Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.3.5 Charles River Recent Development
    • 11.4 Eurofins Scientific
      • 11.4.1 Eurofins Scientific Company Detail
      • 11.4.2 Eurofins Scientific Business Overview
      • 11.4.3 Eurofins Scientific Preclinical Drug Development Services Introduction
      • 11.4.4 Eurofins Scientific Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.4.5 Eurofins Scientific Recent Development
    • 11.5 PPD, Inc.
      • 11.5.1 PPD, Inc. Company Detail
      • 11.5.2 PPD, Inc. Business Overview
      • 11.5.3 PPD, Inc. Preclinical Drug Development Services Introduction
      • 11.5.4 PPD, Inc. Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.5.5 PPD, Inc. Recent Development
    • 11.6 ICON Plc.
      • 11.6.1 ICON Plc. Company Detail
      • 11.6.2 ICON Plc. Business Overview
      • 11.6.3 ICON Plc. Preclinical Drug Development Services Introduction
      • 11.6.4 ICON Plc. Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.6.5 ICON Plc. Recent Development
    • 11.7 Pharmaron
      • 11.7.1 Pharmaron Company Detail
      • 11.7.2 Pharmaron Business Overview
      • 11.7.3 Pharmaron Preclinical Drug Development Services Introduction
      • 11.7.4 Pharmaron Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.7.5 Pharmaron Recent Development
    • 11.8 Inotiv
      • 11.8.1 Inotiv Company Detail
      • 11.8.2 Inotiv Business Overview
      • 11.8.3 Inotiv Preclinical Drug Development Services Introduction
      • 11.8.4 Inotiv Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.8.5 Inotiv Recent Development
    • 11.9 ChemPartner
      • 11.9.1 ChemPartner Company Detail
      • 11.9.2 ChemPartner Business Overview
      • 11.9.3 ChemPartner Preclinical Drug Development Services Introduction
      • 11.9.4 ChemPartner Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.9.5 ChemPartner Recent Development
    • 11.10 JOINN Lab
      • 11.10.1 JOINN Lab Company Detail
      • 11.10.2 JOINN Lab Business Overview
      • 11.10.3 JOINN Lab Preclinical Drug Development Services Introduction
      • 11.10.4 JOINN Lab Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.10.5 JOINN Lab Recent Development
    • 11.11 EVOTEC
      • 11.11.1 EVOTEC Company Detail
      • 11.11.2 EVOTEC Business Overview
      • 11.11.3 EVOTEC Preclinical Drug Development Services Introduction
      • 11.11.4 EVOTEC Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.11.5 EVOTEC Recent Development
    • 11.12 Medicilon
      • 11.12.1 Medicilon Company Detail
      • 11.12.2 Medicilon Business Overview
      • 11.12.3 Medicilon Preclinical Drug Development Services Introduction
      • 11.12.4 Medicilon Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.12.5 Medicilon Recent Development
    • 11.13 Noble Life Sciences
      • 11.13.1 Noble Life Sciences Company Detail
      • 11.13.2 Noble Life Sciences Business Overview
      • 11.13.3 Noble Life Sciences Preclinical Drug Development Services Introduction
      • 11.13.4 Noble Life Sciences Revenue in Preclinical Drug Development Services Business (2017-2022)
      • 11.13.5 Noble Life Sciences Recent Development

    12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
        • 13.1.2 Data Source
      • 13.2 Disclaimer

      Summary:

      Industry Insights
      The global Preclinical Drug Development Services market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
      Fully considering the economic change by this health crisis, API Preparation accounting for % of the Preclinical Drug Development Services global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical segment is altered to an % CAGR throughout this forecast period.
      China Preclinical Drug Development Services market size is valued at US$ million in 2021, while the North America and Europe Preclinical Drug Development Services are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Preclinical Drug Development Services landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
      With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preclinical Drug Development Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preclinical Drug Development Services market in terms of revenue.
      Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preclinical Drug Development Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preclinical Drug Development Services market.
      Impact of Covid-19 Outbreak
      This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
      Segmental Analysis
      The report has been segmented into product and application segments. The researchers have documented all the products present today in the Preclinical Drug Development Services market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
      Preclinical Drug Development Services Breakdown Data by Type
      API Preparation
      Formulation Studies
      Safety Studies
      ADME Stuies
      Preclinical Drug Development Services Breakdown Data by Application
      Pharmaceutical
      Bio-pharmaceutical
      Regional Analysis
      North America
      United States
      Canada
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Nordic Countries
      Rest of Europe
      Asia-Pacific
      China
      Japan
      South Korea
      Southeast Asia
      India
      Australia
      Rest of Asia
      Latin America
      Mexico
      Brazil
      Rest of Latin America
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Rest of MEA
      Competitive Landscape
      This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
      Wuxi AppTec
      Labcorp
      Charles River
      Eurofins Scientific
      PPD, Inc.
      ICON Plc.
      Pharmaron
      Inotiv
      ChemPartner
      JOINN Lab
      EVOTEC
      Medicilon
      Noble Life Sciences
      Frequently Asked Questions
      What factors will challenge the Preclinical Drug Development Services market growth?
      Which end-use segment will expand at the fastest CAGR in the Preclinical Drug Development Services market?
      Which are the emerging players in the Preclinical Drug Development Services market?
      How concentrated is the Preclinical Drug Development Services market?
      Which factors are positively contributing to the Preclinical Drug Development Services market growth?
      Which are the novel product innovations in the Preclinical Drug Development Services market?
      Which product segment will emerge as the most lucrative in the Preclinical Drug Development Services market?
      Which factors are increasing the competition in the Preclinical Drug Development Services market?
      Which are the strategic measures taken by the Preclinical Drug Development Services industry players?
      Which region will witness inactive growth during the forecast period?
      What key trends are likely to emerge in the Preclinical Drug Development Services market in the coming years?


      Summary:
      Get latest Market Research Reports on Preclinical Drug Development Services. Industry analysis & Market Report on Preclinical Drug Development Services is a syndicated market report, published as Global Preclinical Drug Development Services Market Research Report 2022. It is complete Research Study and Industry Analysis of Preclinical Drug Development Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,343.20
      4,686.40
      2,763.70
      5,527.40
      372,418.00
      744,836.00
      225,011.00
      450,022.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report